Report Israel - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update Nov 1, 2024

Israel - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Israel: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in Israel

In 2021, the Israeli medicaments containing insulin market decreased by -0.8% to $X, falling for the fifth year in a row after two years of growth. Over the period under review, consumption, however, posted a buoyant increase. Over the period under review, the market reached the maximum level at $X in 2016; however, from 2017 to 2021, consumption failed to regain momentum.

Medicaments Containing Insulin Production in Israel

In value terms, medicaments containing insulin production skyrocketed to $X in 2021 estimated in export price. Over the period under review, production, however, showed a significant increase. The most prominent rate of growth was recorded in 2019 when the production volume increased by 118%. As a result, production attained the peak level of $X. From 2020 to 2021, production growth remained at a somewhat lower figure.

Medicaments Containing Insulin Exports

Exports from Israel

In 2021, shipments abroad of medicaments containing insulin but not antibiotics decreased by -42.8% to X kg, falling for the second year in a row after eight years of growth. In general, exports, however, posted a significant expansion. The most prominent rate of growth was recorded in 2019 with an increase of 181%. As a result, the exports reached the peak of X tons. From 2020 to 2021, the growth of the exports remained at a somewhat lower figure.

In value terms, medicaments containing insulin exports reduced remarkably to $X in 2021. Overall, exports, however, posted buoyant growth. The growth pace was the most rapid in 2019 with an increase of 55%. As a result, the exports reached the peak of $X. From 2020 to 2021, the growth of the exports remained at a lower figure.

Exports by Country

Guatemala (X kg) was the main destination for medicaments containing insulin exports from Israel, accounting for a approx. 100% share of total exports.

From 2012 to 2021, the average annual growth rate of volume to Guatemala was relatively modest.

In value terms, Palestine ($X) remains the key foreign market for medicaments containing insulin but not antibiotics exports from Israel, comprising 100% of total exports. The second position in the ranking was held by Guatemala ($X), with a 0.1% share of total exports.

From 2012 to 2021, the average annual rate of growth in terms of value to Palestine amounted to +14.6%.

Export Prices by Country

In 2021, the average medicaments containing insulin export price amounted to $X per ton, rising by 34% against the previous year. In general, the export price, however, recorded a abrupt shrinkage. Over the period under review, the average export prices hit record highs at $X per ton in 2013; however, from 2014 to 2021, the export prices failed to regain momentum.

As there is only one major export destination, the average price level is determined by prices for Guatemala.

From 2013 to 2021, the rate of growth in terms of prices for Guatemala amounted to 0.0% per year.

Medicaments Containing Insulin Imports

Imports into Israel

In 2021, after two years of decline, there was significant growth in supplies from abroad of medicaments containing insulin but not antibiotics, when their volume increased by 133% to X kg. In general, imports, however, showed a slight contraction. The growth pace was the most rapid in 2014 when imports increased by 535% against the previous year. Over the period under review, imports reached the maximum at X kg in 2015; however, from 2016 to 2021, imports remained at a lower figure.

In value terms, medicaments containing insulin imports soared to $X in 2021. Overall, imports recorded buoyant growth. The pace of growth was the most pronounced in 2014 with an increase of 400% against the previous year. Over the period under review, imports hit record highs at $X in 2015; however, from 2016 to 2021, imports failed to regain momentum.

Imports by Country

From 2012 to 2021, the average annual rate of growth in terms of volume from No country was relatively modest.

In value terms, the United States ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to Israel.

From 2012 to 2021, the average annual growth rate of value from the United States stood at +31.9%.

Import Prices by Country

In 2018, the average medicaments containing insulin import price amounted to $X per ton, jumping by 29% against the previous year. Over the period under review, the import price posted a prominent increase. The pace of growth appeared the most rapid in 2016 an increase of 72% against the previous year. Over the period under review, average import prices reached the maximum in 2018 and is expected to retain growth in the immediate term.

As there is only one major supplying country, the average price level is determined by prices for the United States.

From 2013 to 2018, the rate of growth in terms of prices for the United States amounted to 0.0% per year.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

Denmark constituted the country with the largest volume of medicaments containing insulin consumption, comprising approx. 58% of total volume. Moreover, medicaments containing insulin consumption in Denmark exceeded the figures recorded by the second-largest consumer, the U.S., sevenfold. Pakistan ranked third in terms of total consumption with a 3.6% share.
The country with the largest volume of medicaments containing insulin production was the U.S., comprising approx. 80% of total volume. Moreover, medicaments containing insulin production in the U.S. exceeded the figures recorded by the second-largest producer, Denmark, more than tenfold. The third position in this ranking was occupied by Pakistan, with a 2.5% share.
In value terms, the U.S. constituted the largest supplier of medicaments containing insulin to Israel.
In value terms, Palestine remains the key foreign market for medicaments containing insulin exports from Israel.
The average medicaments containing insulin export price stood at $36,803 per ton in 2019, jumping by 91% against the previous year.
In 2018, the average medicaments containing insulin import price amounted to $210,000 per ton, remaining relatively unchanged against the previous year.

This report provides an in-depth analysis of the medicaments containing insulin market in Israel. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale

Country coverage:

  • Israel

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Trade (exports and imports) in Israel
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS
  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. MARKET STRUCTURE
    3. TRADE BALANCE
    4. PER CAPITA CONSUMPTION
    5. MARKET FORECAST TO 2030
  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT
  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES
  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS
  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
  8. 8. IMPORTS

    The Largest Import Supplying Countries

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY
  9. 9. EXPORTS

    The Largest Destinations for Exports

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY
  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
  11. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption In 2012-2023
    5. Imports, In Physical Terms, By Country, 2012–2023
    6. Imports, In Value Terms, By Country, 2012–2023
    7. Import Prices, By Country Of Origin, 2012–2023
    8. Exports, In Physical Terms, By Country, 2012–2023
    9. Exports, In Value Terms, By Country, 2012–2023
    10. Export Prices, By Country Of Destination, 2012–2023
  12. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
    4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
    5. Trade Balance, In Physical Terms, 2012-2023
    6. Trade Balance, In Value Terms, 2012-2023
    7. Per Capita Consumption, 2012-2023
    8. Market Volume Forecast to 2030
    9. Market Value Forecast to 2030
    10. Products: Market Size And Growth, By Type
    11. Products: Average Per Capita Consumption, By Type
    12. Products: Exports And Growth, By Type
    13. Products: Export Prices And Growth, By Type
    14. Production Volume And Growth
    15. Exports And Growth
    16. Export Prices And Growth
    17. Market Size And Growth
    18. Per Capita Consumption
    19. Imports And Growth
    20. Import Prices
    21. Production, In Physical Terms, 2012–2023
    22. Production, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, 2012–2023
    24. Imports, In Value Terms, 2012–2023
    25. Imports, In Physical Terms, By Country, 2023
    26. Imports, In Physical Terms, By Country, 2012–2023
    27. Imports, In Value Terms, By Country, 2012–2023
    28. Import Prices, By Country Of Origin, 2012–2023
    29. Exports, In Physical Terms, 2012–2023
    30. Exports, In Value Terms, 2012–2023
    31. Exports, In Physical Terms, By Country, 2023
    32. Exports, In Physical Terms, By Country, 2012–2023
    33. Exports, In Value Terms, By Country, 2012–2023
    34. Export Prices, By Country Of Destination, 2012–2023

Recommended reports

Free Data: Medicaments Containing Insulin But Not Antibiotics - Israel